- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Longport wins first LDS order
Ultrasound developer Longport of Swarthmore, PA, has received its first commercial order for its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm (SCAN 1/13/99). The
Ultrasound developer Longport of Swarthmore, PA, has received its first commercial order for its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm (SCAN 1/13/99). The order is for 25 of the systems, and comes from UltraScan East of Allentown, PA.
The order is the latest good news for the company. In April, Longport signed an agreement with Healthlink International of Westerville, OH, in which Healthlink will invest $5 million to support Longports R&D efforts (SCAN 5/26/99). The firm then received clearance for LDS from the Food and Drug Administration in June. In September, Longport formed an international subsidiary to begin worldwide marketing of LDS, and applied for listing on the Pacific Stock Exchange.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
